Literature DB >> 26864463

The Timing of Breast Irradiation in Two-Stage Expander/Implant Breast Reconstruction.

Chen Yan1, John P Fischer1, Gary M Freedman2, Marten N Basta1, Stephen J Kovach1, Joseph M Serletti1, Lilie Lin2, Liza C Wu1.   

Abstract

Certain patients who initiate expander/implant (E/I) reconstruction following mastectomy may require radiation therapy (XRT). XRT may be delivered during the tissue expander (TE) expansion process or after exchange for a permanent implant (PI). We studied a series of women treated with E/I reconstruction and XRT to determine whether there is a difference in complication rates between those who had XRT to the TE versus PI. All two-stage E/I reconstructions at our institution from April 2005 to January 2013 were reviewed to identify patients who underwent XRT after TE placement. Our database was queried for reconstructive details, oncologic treatment, and complications. Statistical analyses were performed to establish significance of complication rate differences. Fifty-two patients underwent XRT after TE placement, 42 of which had XRT to the TE and 11 of which had XRT to the PI. The major complication rates (complications requiring emergent reoperation/readmission) were 27% versus 0% (p = 0.05) for XRT to the TE versus XRT to the PI, but there were no significant differences in minor complication rates (outpatient complications). Specifically, the rates of Grade 3/4 capsular contracture were similar between the two groups, 27% for the XRT to the TE group and 36% for the XRT to the PI group. Radiation of the PI versus radiation of the TE did not result in significant differences in overall surgical complication rates but had fewer major complications and no implant failures. Other factors must also be considered, such as patient preference, risk of cancer reoccurrence, and cosmesis. It is essential for a patient to have a team of a plastic surgeon and radiation, surgical, and medical oncologists working together to achieve each patient's goals.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  breast reconstruction; expander; implant; radiation; timing

Mesh:

Year:  2016        PMID: 26864463     DOI: 10.1111/tbj.12572

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  6 in total

1.  Elective Revisions after Breast Reconstruction: Results from the Mastectomy Reconstruction Outcomes Consortium.

Authors:  Jonas A Nelson; Sophocles H Voineskos; Ji Qi; Hyungjin M Kim; Jennifer B Hamill; Edwin G Wilkins; Andrea L Pusic
Journal:  Plast Reconstr Surg       Date:  2019-12       Impact factor: 4.730

Review 2.  Trends and controversies in multidisciplinary care of the patient with breast cancer.

Authors:  Laura S Dominici; Monica Morrow; Elizabeth Mittendorf; Jennifer Bellon; Tari A King
Journal:  Curr Probl Surg       Date:  2016-11-29       Impact factor: 1.909

3.  Outcomes of Immediate Alloplastic Breast Reconstruction in Patients Receiving Post-Mastectomy Radiotherapy.

Authors:  Stacy Fan; Hanny Chen; Aaron Grant; Tanya DeLyzer
Journal:  Plast Surg (Oakv)       Date:  2020-11-10       Impact factor: 0.558

4.  Implant-based immediate breast reconstruction: failure rate when radiating the tissue expander or the permanent implant-a meta-analysis.

Authors:  Víctor Fuertes; Mónica Francés; José M Casarrubios; Javier Fernández-Palacios; Jesús María González; Juan Francisco Loro-Ferrer
Journal:  Gland Surg       Date:  2020-04

5.  Protocol for the BRECAR study: a prospective cohort follow-up on the impact of breast reconstruction timing on health-related quality of life in women with breast cancer.

Authors:  Maria Herrera de la Muela; Enrique García López; Laura Frías Aldeguer; Paloma Gómez-Campelo
Journal:  BMJ Open       Date:  2017-12-19       Impact factor: 2.692

6.  Patient-Reported Outcomes after Irradiation of Tissue Expander versus Permanent Implant in Breast Reconstruction: A Multicenter Prospective Study.

Authors:  Alfred P Yoon; Ji Qi; Hyungjin M Kim; Jennifer B Hamill; Reshma Jagsi; Andrea L Pusic; Edwin G Wilkins; Jeffrey H Kozlow
Journal:  Plast Reconstr Surg       Date:  2020-05       Impact factor: 5.169

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.